Showing results (121-130 of 319) with videos related to
Sort By:
Pageof 32
Oral Oncology|January 29, 2021
A phase I trial adding poly(ADP-ribose) polymerase inhibitor veliparib to induction carboplatin-paclitaxel in patients with head and neck squamous cell carcinoma: Alliance A091101Michael J Jelinek, Nathan R Foster, Alex J Zoroufy, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 12, 2010
Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancerKevin S Choe, Joseph K Salama, Kerstin M Stenson, et al.Oral Oncology|October 19, 2013
Race and competing mortality in advanced head and neck cancerKaveh Zakeri, Iain MacEwan, Aria Vazirnia, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic diseaseJoseph K Salama, Steven J Chmura, Neil Mehta, et al.International Journal of Radiation Oncology, Biology, Physics|March 1, 2018
Phase 1 Study of Accelerated Hypofractionated Radiation Therapy With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer: CALGB 31102 (Alliance)James J Urbanic, Xiaofei Wang, Jeffrey A Bogart, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2008
Phase II randomized study of dose-dense docetaxel and cisplatin every 2 weeks with pegfilgrastim and darbepoetin alfa with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (CALGB 30303)Antonius A Miller, Xiaofei F Wang, Lin Gu, et al.Head & Neck|February 6, 2004
Prioritizing treatment outcomes: head and neck cancer patients versus nonpatientsMarcy A List, Judith Lee Rutherford, John Stracks, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapyAthanassios Argiris, Bruce E Brockstein, Daniel J Haraf, et al.Cancers|September 13, 2025
Diagnosis, Treatment, and Unmet Needs of Dedifferentiated Liposarcoma in the United States: A Multidisciplinary Delphi StudyDavid Campbell, Scott Ramsey, David Veenstra, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2008
Response to the methylation inhibitor dihydro-5-azacytidine in mesothelioma is not associated with methylation of p16INK4a: results of cancer and leukemia group B 159904Robert A Kratzke, Xiaofei Wang, Long Wong, et al.Pageof 32